Shares Held by Insiders

Fully Diluted Shares Held by Insiders

Date

Name

Buy/Sell

$ Value

# Shares

Avg. Price

Title

Chief Medical Officer

President and CEO

Executive Vice Chair

SVP & Chief Commercial Officer

Chief Financial Officer

EyePoint Pharmaceuticals, Inc. focuses on developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders. The company's pipeline leverages its proprietary erodible Durasert E technology for sustained intraocular drug delivery, including EYP-1901, an investigational sustained delivery intravitreal anti-VEGF treatment, which is in Phase 2 clinical trials. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

EyePoint Pharmaceuticals, Inc. focuses on developing and commercializing therapeutics to help improve the lives of patients with serious e...

Datesorted ascending	Name	Buy/Sell	$ Value	# Shares	Avg. Price	Title
2024-04-18	Premium	bought	Premium	Premium	Premium	-
2024-03-30	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-03-30	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-27	Premium	gifted	Premium	Premium	Premium	President and CEO
2024-02-27	Premium	gifted	Premium	Premium	Premium	President and CEO
2024-02-20	Premium	gifted	Premium	Premium	Premium	President and CEO
2024-02-20	Premium	gifted	Premium	Premium	Premium	President and CEO
2024-02-13	Premium	gifted	Premium	Premium	Premium	Executive Vice Chair
2024-02-13	Premium	gifted	Premium	Premium	Premium	Executive Vice Chair
2024-02-09	Premium	acquired	Premium	Premium	Premium	SVP & Chief Commercial Officer
2024-02-09	Premium	sold (taxes)	Premium	Premium	Premium	Chief Financial Officer
2024-02-09	Premium	acquired	Premium	Premium	Premium	President and CEO
2024-02-09	Premium	sold (taxes)	Premium	Premium	Premium	President and CEO
2024-02-09	Premium	acquired	Premium	Premium	Premium	Chief Financial Officer
2024-02-09	Premium	sold (taxes)	Premium	Premium	Premium	Executive Vice Chair
2024-02-09	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-02-09	Premium	sold (taxes)	Premium	Premium	Premium	SVP & Chief Commercial Officer
2024-02-09	Premium	acquired	Premium	Premium	Premium	Executive Vice Chair
2024-02-09	Premium	sold (taxes)	Premium	Premium	Premium	Chief Medical Officer
2024-02-02	Premium	sold	Premium	Premium	Premium	SVP & Chief Commercial Officer
2024-02-02	Premium	acquired	Premium	Premium	Premium	SVP & Chief Commercial Officer
2024-01-26	Premium	sold	Premium	Premium	Premium	SVP & Chief Commercial Officer
2024-01-26	Premium	acquired	Premium	Premium	Premium	Chief Medical Officer
2024-01-26	Premium	acquired	Premium	Premium	Premium	SVP & Chief Commercial Officer
2024-01-26	Premium	sold	Premium	Premium	Premium	Chief Medical Officer

EYPT - EyePoint Pharmaceuticals Inc Stock Price, Fair Value and News

Latest Insider Trading transactions for EYPT